Literature DB >> 27656247

Pregnancy and pulmonary hypertension: a practical approach to management.

David G Kiely1, Robin Condliffe1, Vicki J Wilson2, Suarabh V Gandhi3, Charlie A Elliot1.   

Abstract

Pulmonary hypertension remains a major cause of cardiac maternal death in the developed world. Over the last two decades, effective therapies for pulmonary hypertension have been developed, improving symptoms and survival. Consequently, increasing numbers of women with pulmonary hypertension and childbearing potential exist, with a number considering pregnancy. Patients with pulmonary hypertension may also present for the first time during pregnancy or shortly following delivery. The last decade has seen increasing reports of women with pulmonary hypertension surviving pregnancy using a variety of approaches but there is still a significant maternal mortality at between 12% and 33%. Current recommendations counsel that patients with known pulmonary hypertension should be strongly advised to avoid pregnancy with the provision of clear contraceptive advice and termination of pregnancy should be considered in its eventuality. In patients who are fully informed and who have been counselled regarding the risks of continuing with pregnancy, there is growing evidence that a multi-professional approach with expert care in pulmonary hypertension centres may improve outlook, although the mortality remains high.

Entities:  

Keywords:  Pulmonary hypertension; chronic thromboembolic pulmonary hypertension; maternal mortality; pregnancy

Year:  2013        PMID: 27656247      PMCID: PMC5004325          DOI: 10.1177/1753495X13495193

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  33 in total

1.  Pregnant patient with primary pulmonary hypertension: inhaled pulmonary vasodilators and epidural anesthesia for cesarean delivery.

Authors:  B M Weiss; M Maggiorini; R Jenni; U Lauper; V Popov; T Bombeli; D R Spahn
Journal:  Anesthesiology       Date:  2000-04       Impact factor: 7.892

2.  Educational and behavioural problems in babies of 32-35 weeks gestation.

Authors:  C L Huddy; A Johnson; P L Hope
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-07       Impact factor: 5.747

Review 3.  Pulmonary arterial hypertension: pathophysiology and anesthetic approach.

Authors:  Gilbert Blaise; David Langleben; Bernard Hubert
Journal:  Anesthesiology       Date:  2003-12       Impact factor: 7.892

Review 4.  Adaptation of the maternal heart in pregnancy.

Authors:  S Hunter; S C Robson
Journal:  Br Heart J       Date:  1992-12

Review 5.  Updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

6.  The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension.

Authors:  C A Elliot; P Stewart; V J Webster; G H Mills; S P Hutchinson; E S Howarth; F A Bu'lock; R A Lawson; I J Armstrong; D G Kiely
Journal:  Eur Respir J       Date:  2005-07       Impact factor: 16.671

7.  Anaesthesia for caesarean section in the presence of severe primary pulmonary hypertension.

Authors:  R O'Hare; C McLoughlin; K Milligan; D McNamee; H Sidhu
Journal:  Br J Anaesth       Date:  1998-11       Impact factor: 9.166

8.  Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach.

Authors:  D G Kiely; R Condliffe; V Webster; G H Mills; I Wrench; S V Gandhi; K Selby; I J Armstrong; L Martin; E S Howarth; F A Bu'lock; P Stewart; C A Elliot
Journal:  BJOG       Date:  2010-04       Impact factor: 6.531

9.  Pregnancy in patients with congenital heart disease.

Authors:  P Presbitero; F Rabajoli; J Somerville
Journal:  Schweiz Med Wochenschr       Date:  1995-02-18

10.  Pulmonary hypertension and pregnancy: a series of eight cases.

Authors:  K G Smedstad; R Cramb; D H Morison
Journal:  Can J Anaesth       Date:  1994-06       Impact factor: 5.063

View more
  7 in total

1.  Management of Pulmonary Arterial Hypertension in Pregnancy: Experience from a Nationally Accredited Center.

Authors:  Anjali Vaidya; Estefania Oliveros; Wadia Mulla; Diana Feinstein; Laura Hart; Paul Forfia
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-18

2.  Association of hemodynamics during caesarean section, outcomes after caesarean section and hormone changes with different anesthesia in pregnant women with severe pulmonary arterial hypertension.

Authors:  Yun Wang; Haiyan Xu; Haiyan Li; Yan Liu; Qingling Bai
Journal:  Exp Ther Med       Date:  2018-03-27       Impact factor: 2.447

Review 3.  Pulmonary Hypertension in Pregnancy: Challenges and Solutions.

Authors:  Hesham Afify; Alexander Kong; Jopher Bernal; Islam Y Elgendy
Journal:  Integr Blood Press Control       Date:  2022-04-02

4.  A case report of a 37-year-old woman with pulmonary arterial hypertension first presented during her 3rd pregnancy and favourable long-term vasoreactive response.

Authors:  Julian Georg Westphal; Matthias Oehler; Paul Christian Schulze; Daniel Kretzschmar
Journal:  Eur Heart J Case Rep       Date:  2022-02-07

Review 5.  Pregnancy in Pulmonary Arterial Hypertension: A Multidisciplinary Approach.

Authors:  Yasmeen Daraz; Sandhya Murthy; Diana Wolfe
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-18

Review 6.  Pregnancy Considerations in the Multidisciplinary Care of Patients with Pulmonary Arterial Hypertension.

Authors:  Julie Coursen; Catherine E Simpson; Monica Mukherjee; Arthur J Vaught; Shelby Kutty; Tala K Al-Talib; Malissa J Wood; Nandita S Scott; Stephen C Mathai; Garima Sharma
Journal:  J Cardiovasc Dev Dis       Date:  2022-08-11

7.  Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute.

Authors:  Anna R Hemnes; David G Kiely; Barbara A Cockrill; Zeenat Safdar; Victoria J Wilson; Manal Al Hazmi; Ioana R Preston; Mandy R MacLean; Tim Lahm
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.